XML 25 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Incentive Plan
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
Equity Incentive Plan

Note 8 – Equity Incentive Plan

 

Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates 50,000,000 shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.

 

During the six months ended June 30, 2020, the Company issued shares of its common stock under the 2017 Equity Plan as follows:

 

  1,000,000 shares to an employee in settlement of certain RSUs that vested December 31, 2019;
     
  560,000 shares pursuant to a special incentive stock bonus approved by the Board for the period ended December 31, 2019; and
     
  6,750,000 shares in settlement of restricted stock units to a former employee after taking measures to mitigate the Company’s exposure to penalties and liability for the failure to properly withhold income taxes.as further discussed in Note 7 – Commitments and Contingencies, Litigation above.

 

As of June 30, 2020, awards related to 23,523,100 shares remain outstanding.

 

The total unrecognized compensation expense for unvested non-qualified stock options and RSUs at June 30, 2020, was $55,265, which will be recognized over approximately 1 year.

  

Non-Qualified Stock Options

 

A summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the six months ended June 30, 2020, are presented in the table below:

 

    Number of Options     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term     Aggregate Intrinsic Value  
                         
Outstanding, December 31, 2019     10,135,000     $ 0.096       7.7     $  
Granted     6,616,900     $ 0.070       10.0     $ -  
Exercised     -                          
Forfeited     -                          
Expired     (628,800 )   $ 0.080       9.4     $ -  
Outstanding, June 30, 2020     16,123,100     $ 0.086       8.1     $ -  
Exercisable, June 30, 2020     14,123,100     $ 0.086       8.0     $ -  
Outstanding vested and expected to vest, June 30, 2020     16,123,100     $ 0.086       8.1     $ -  

 

During the three months ended June 30, 2020, 628,000 non-qualified stock options expired unexercised following the departure of two former employees.

 

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the six months ended June 30, 2020, are presented in the table below:

 

    Number of Options     Weighted Average Grant-Date Fair Value     Aggregate Intrinsic Value     Grant-Date Fair Value  
                                 
Nonvested, December 31, 2019     2,000,000     $ 0.075     $ -     $ 149,534  
Granted     6,616,900     $ 0.059             $ 387,199  
Vested     (6,616,900 )   $ 0.059             $ 387,199  
Forfeited     -                     $ -  
Expired     -                     $ -  
Nonvested, June 30, 2020     2,000,000     $ 0.075     $ -     $ 149,534  

 

For the six months ended June 30, 2020 and 2019, the Company recorded $153,680 and $275,074 as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.

 

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the six months ended June 30, 2020, are presented in the table below:

 

    Number of Options     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term     Aggregate Intrinsic Value ($000)  
                         
Outstanding, December 31, 2019     900,000     $ 0.135       7.6     $ -  
Granted     6,500,000     $ 0.057       8.5          
Exercised     -         -                    
Forfeited/Cancelled     -         -                    
Expired     -         -                    
Outstanding, June 30, 2020     7,400,000     $ 0.067       8.0     $ -  
Exerciseable, June 30, 2020     6,400,000     $ 0.073       8.5     $  

  

A summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the six months ended June 30, 2020, are presented in the table below:

 

    Number of Options     Weighted Average Grant-Date Fair Value     Aggregate Intrinsic Value     Grant-Date Fair Value  
                                 
Nonvested, December 31, 2019     -         -       $ -            
Granted     6,500,000       0.057             $ 373,000  
Vested     (5,500,000 )     0.063             $ 344,000  
Forfeited     -         -               $ -    
Expired     -         -               $ -    
Nonvested, June 30, 2020     1,000,000       0.029     $ 1,000     $ 29,000  

 

During the six months ended June 30, 2020 and 2019, the Company incurred $49,488 and $0, respectively, as compensation expense related to 1,521,352 and 0 vested options, respectively, issued to directors.

 

Effective June 24, 2020, the Company issued 2 million non-qualified stock options under the 2017 Equity Plan to newly appointed directors. The options vested 50% upon grant and 50% on April 1, 2021, if the Director remains on the Board up to that time. The options have a term of 5 years and have an exercise price equal to the closing price of the Company’s common stock on The OTC Markets on the day immediately preceding the grant date of $.029.

 

Restricted Stock Units

 

A summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the six months ended June 30, 2020, are presented in the table below:

 

    Number of Units     Weighted Average Grant-Date Fair Value     Aggregate Intrinsic Value  
                         
Outstanding, December 31, 2019     7,550,000     $ 0.128     $ 528,500  
Granted     -         -            
Vested and settled with share issuance     (6,750,000 )   $ 0.121          
Forfeited/canceled     (800,000 )   $ 0.184          
Outstanding, June 30, 2020     -                    

 

For the six months ended June 30, 2020 and 2019, the Company recorded $25,163 and $182,369, respectively, as compensation expense related to vested RSUs issued to employees, directors and consultants. The total intrinsic value of RSUs vested and settled with share issuance was $199,125 for the six months ended June 30, 2020.

  

Effective April 30, 2020, 800,000 RSUs vested. However, the holder elected to cancel the RSUs.